According to Natera's latest financial reports the company has a price-to-book ratio of 14.6.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 9.83 | 58.46% |
2022-12-31 | 6.21 | -54.11% |
2021-12-31 | 13.5 | -22.61% |
2020-12-31 | 17.5 | 85.31% |
2019-12-31 | 9.43 | -65.01% |
2018-12-31 | 26.9 | 41.69% |
2017-12-31 | 19.0 | 230.12% |
2016-12-31 | 5.76 | 95.76% |
2015-12-31 | 2.94 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | 5.85 | -60.08% | ๐บ๐ธ USA |
Prothena PRTA | 2.00 | -86.37% | ๐ฎ๐ช Ireland |
Paratek Pharmaceuticals
PRTK | -0.6348 | -104.33% | ๐บ๐ธ USA |